Lysosome impairment as a trigger for inflammation in obesity: The proof is in the fat.

Obesity is a global epidemic contributing to the rising prevalence of multiple disorders including metabolic syndrome, diabetes, fatty liver disease, cardiovascular and cerebrovascular disease, Alzheimer's disease and certain cancers. A renewed sense of urgency is required as obesity remains an...

Descripción completa

Detalles Bibliográficos
Autores principales: Rawnsley, David R., Diwan, Abhinav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300142/
https://www.ncbi.nlm.nih.gov/pubmed/32540774
http://dx.doi.org/10.1016/j.ebiom.2020.102824
_version_ 1783547525907611648
author Rawnsley, David R.
Diwan, Abhinav
author_facet Rawnsley, David R.
Diwan, Abhinav
author_sort Rawnsley, David R.
collection PubMed
description Obesity is a global epidemic contributing to the rising prevalence of multiple disorders including metabolic syndrome, diabetes, fatty liver disease, cardiovascular and cerebrovascular disease, Alzheimer's disease and certain cancers. A renewed sense of urgency is required as obesity remains an intractable problem, despite a rapidly expanding armamentarium of behavioral, pharmacologic and surgical approaches which fall short of delivering sustained results
format Online
Article
Text
id pubmed-7300142
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73001422020-06-22 Lysosome impairment as a trigger for inflammation in obesity: The proof is in the fat. Rawnsley, David R. Diwan, Abhinav EBioMedicine Commentary Obesity is a global epidemic contributing to the rising prevalence of multiple disorders including metabolic syndrome, diabetes, fatty liver disease, cardiovascular and cerebrovascular disease, Alzheimer's disease and certain cancers. A renewed sense of urgency is required as obesity remains an intractable problem, despite a rapidly expanding armamentarium of behavioral, pharmacologic and surgical approaches which fall short of delivering sustained results Elsevier 2020-06-12 /pmc/articles/PMC7300142/ /pubmed/32540774 http://dx.doi.org/10.1016/j.ebiom.2020.102824 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Rawnsley, David R.
Diwan, Abhinav
Lysosome impairment as a trigger for inflammation in obesity: The proof is in the fat.
title Lysosome impairment as a trigger for inflammation in obesity: The proof is in the fat.
title_full Lysosome impairment as a trigger for inflammation in obesity: The proof is in the fat.
title_fullStr Lysosome impairment as a trigger for inflammation in obesity: The proof is in the fat.
title_full_unstemmed Lysosome impairment as a trigger for inflammation in obesity: The proof is in the fat.
title_short Lysosome impairment as a trigger for inflammation in obesity: The proof is in the fat.
title_sort lysosome impairment as a trigger for inflammation in obesity: the proof is in the fat.
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300142/
https://www.ncbi.nlm.nih.gov/pubmed/32540774
http://dx.doi.org/10.1016/j.ebiom.2020.102824
work_keys_str_mv AT rawnsleydavidr lysosomeimpairmentasatriggerforinflammationinobesitytheproofisinthefat
AT diwanabhinav lysosomeimpairmentasatriggerforinflammationinobesitytheproofisinthefat

Ejemplares similares